Skip to main content

Series B Therapeutics Companies

Explore 188 therapeutics startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
188
Total Funding
$1.6B
Avg Funding
$64.9M
Cities
20

Export 188 Series B Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boston, United States
$35.2M
raised

DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.

Oct 2023
Series B

Founder Contacts

30,000+ verified contacts

Chicago, United States
$81.0M
raised

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Sep 2023
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$6.0M
raised

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

Aug 2023
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$109.0M
raised

Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.

Aug 2023
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$13.0M
raised

Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.

Aug 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Berkeley, United States
$60.0M
raised

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

Aug 2023
Series B

Founder Contacts

30,000+ verified contacts

Cleveland, United States
$17.6M
raised

Enspire DBS Therapy supports stroke recovery patients using deep brain stimulation with physical rehabilitation to restore motor function.

Aug 2023
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$30.0M
raised

Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.

Jul 2023
Series B

Founder Contacts

30,000+ verified contacts

Natick, United States
$50.0M
raised

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

Mar 2023
Series B

Founder Contacts

30,000+ verified contacts

Watertown, United States
$125.0M
raised

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
San Mateo, United States
$107.0M
raised

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

South San Francisco, United States
$78.0M
raised

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$25.0M
raised

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$175.0M
raised

Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

Emeryville, United States
$100.0M
raised

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Burlington, United States
$115.0M
raised

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

South San Francisco, United States
$95.0M
raised

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Jan 2024
Series B

Founder Contacts

30,000+ verified contacts

Chicago, United States
$34.0M
raised

NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

New York, United States
$20.0M
raised

Parallel is a provider of learning assessments and treatment solutions for students with learning and thinking differences.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

Phoenix, United States
$50.0M
raised

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Dec 2021
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Woburn, United States
$110.0M
raised

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

New Haven, United States
$40.0M
raised

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

La Tronche, France
$13.3M
raised

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells.

Dec 2021
Series B

Founder Contacts

30,000+ verified contacts

Lexington, United States
$120.0M
raised

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

Syracuse, United States
$12.9M
raised

ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.

Jan 2025
Series B

Founder Contacts

30,000+ verified contacts

Showing 126 to 150 of 188 companies

Ready to Connect with Series B Therapeutics Startups?

Get verified founder emails, funding details, and company data for 188 series b therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked